The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Nicotine use in schizophrenia: The self medication hypotheses
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
The pharmacological basis of therapeutics
Frank, A. L. (1981) · Environmental Research · doi:10.1016/0013-9351(81)90176-6 · Cited by 2,734
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
Braff, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,705
Jentsch, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,314
The Pharmacological Basis of Therapeutics
GOODMAN, L. S., & GILMAN, A. (1976) · Optometry and Vision Science · doi:10.1097/00006324-197604000-00018 · Cited by 1,260
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141 · cited 3×
“…receptors are considered critical to this inhibitory response and post-mortem studies have revealed evidence of their abnormal expression and regulation (as well as that of other types of nicotinic receptors) in brains of schizophrenia patients (Breese et al., 1997, 2000; Freedman et al., 1997).”
BackgroundThe more or less startling effects of weak prestimulation
Graham, F. K. (1975) · Psychophysiology · doi:10.1111/j.1469-8986.1975.tb01284.x · Cited by 1,119
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058 · cited 1×
“Several studies (de Leon et al., 1995, 2002a; Diwan et al., 1988;Glassman, 1993; Hughes et al., 1986) have shown that the rate of smoking in patients with schizophrenia is two- to four-fold the rate seen in the general population (20–35%).”
Background
Cited by
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Nicotine and nonnicotine factors in cigarette addiction
Rose, J. E. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0250-x · Cited by 349
Does tobacco use cause psychosis? Systematic review and meta-analysis
Gurillo, P., Jauhar, S., Murray, R. M., & MacCabe, J. H. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00152-2 · Cited by 300
Young, J. W., Powell, S. B., Risbrough, V., Marston, H. M., & Geyer, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.004 · Cited by 298
The Dynamics of DNA Methylation in Schizophrenia and Related Psychiatric Disorders
Grayson, D. R., & Guidotti, A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.125 · Cited by 267
Modulation of Hippocampus-Dependent Learning and Synaptic Plasticity by Nicotine
Kenney, J. W., & Gould, T. J. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8037-9 · Cited by 242
Chen, Y.-J. J., Johnson, M. A., Lieberman, M. D., Goodchild, R. E., Schobel, S., Lewandowski, N., Rosoklija, G., Liu, R.-C., Gingrich, J. A., Small, S., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1815-08.2008 · Cited by 188
“Experimental administration of nicotine ameliorates working memory and PPI deficits in schizophrenia (Kumari and Postma, 2005; George et al., 2006; Postma et al., 2006).”
BackgroundCognitive function during nicotine withdrawal: Implications for nicotine dependence treatment
Ashare, R. L., Falcone, M., & Lerman, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.034 · Cited by 170
MacKillop, J., & Tidey, J. W. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2185-8 · Cited by 154
Rüther, T., Bobes, J., De Hert, M., Svensson, T. H., Mann, K., Batra, A., Gorwood, P., & Möller, H. J. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.11.002 · Cited by 149
“Nicotine improves the deficits of schizophrenia patients in cognition (sensory gating) [3,172,173], working memory [152,252] and attentional deficits [65], so that strong self-medication effects can be assumed for these deficits as well.”
BackgroundVancampfort, D., De Hert, M., Knapen, J., Wampers, M., Demunter, H., Deckx, S., Maurissen, K., & Probst, M. (2011) · Disability and Rehabilitation · doi:10.3109/09638288.2010.509458 · Cited by 123
Davis, J. A., Kenney, J. W., & Gould, T. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3242-07.2007 · Cited by 107
Gage, S. H., Hickman, M., Heron, J., Munafò, M. R., Lewis, G., Macleod, J., & Zammit, S. (2014) · Psychological Medicine · doi:10.1017/s0033291714000531 · Cited by 91
Gates, J., Killackey, E., Phillips, L., & Álvarez-Jiménez, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00213-8 · Cited by 72
Young, J. W., Meves, J. M., & Geyer, M. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.028 · Cited by 69
Smoking and predictors of nicotine dependence in a homeless population
Torchalla, I., Strehlau, V., Okoli, C. T. C., Li, K., Schuetz, C., & Krausz, M. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr101 · Cited by 45
Mesolimbic Dopamine and Habenulo-Interpeduncular Pathways in Nicotine Withdrawal
Dani, J. A., & De Biasi, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012138 · Cited by 34
Acheson, D. T., Twamley, E. W., & Young, J. W. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00103 · Cited by 26
Drusch, K., Lowe, A., Fisahn, K., Brinkmeyer, J., Musso, F., Mobascher, A., Warbrick, T., Shah, J., Ohmann, C., Winterer, G., et al. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0377-9 · Cited by 25
Smoking, Suicidality and Psychosis: A Systematic Meta-Analysis
Sankaranarayanan, A., Mancuso, S., Wilding, H., Ghuloum, S., & Castle, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138147 · Cited by 24
Martinez Agulleiro, L., Patil, B., Firth, J., Sawyer, C., Amann, B. L., Fonseca, F., Torrens, M., Perez, V., Castellanos, F. X., Kane, J. M., et al. (2023) · Psychological Medicine · doi:10.1017/s003329172300123x · Cited by 19
The Neurochemical Modulation of Prefrontal Control Processes
Robbins, T. W., & Kehagia, A. A. (2017) · The Wiley Handbook of Cognitive Control · doi:10.1002/9781118920497.ch19 · Cited by 4
Whitton, A. E., Lewandowski, K. E., & Hall, M.-H. (2021) · Brain Sciences · doi:10.3390/brainsci11121581 · Cited by 4
“This is an important gap, since the pro-cognitive effects of nicotine in schizophrenia have typically been taken as evidence of self-medication via smoking [80], with some noting that similar mechanisms could explain high rates of smoking in bipolar disorder [53].”
Background
Metadata
- Authors
- Kumari, V., & Postma, P.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 29
- Issue
- 6
- Pages
- 1021-1034
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2114226702
- Cited by
- 468
- References
- 177
- FWCI
- 14.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.